09:09 AM EDT, 08/05/2025 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) reported Q2 net loss Tuesday of $0.88 per diluted share.

The biotech company didn't provide year-ago figures. Five analysts polled by FactSet expected a loss of $0.78.

No revenue for the quarter ended June 30 was reported, as expected.

The company said it had about $992 million in cash, cash equivalents and marketable securities as of June 30, which are expected to fund operations into 2029. The company said it had $1.05 billion at the end of March, and that the decrease was mostly due to net cash used in operations.